Protalix Biotherapeutics Inc. Price to FCF Ratio 2006–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Protalix Biotherapeutics Inc. (PLX): market cap divided by trailing twelve-month free cash flow. As of September 30, 2025 it is 24.27.

From: 06/30/2011To: 03/31/2026

Stock Price

TTM Free Cash Flow

Price to FCF

Protalix Biotherapeutics Inc. Price to FCF Ratio — FAQ

Protalix Biotherapeutics Inc. (PLX) price to fcf ratio over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see PLX's price to fcf ratio history?

The chart and table above show Protalix Biotherapeutics Inc.'s price to fcf ratio by year and by quarter, including the growth rate.